FDA Approved: INBRIJA — Supplemental Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for INBRIJA (levodopa inhalation powder) submitted by Merz Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• INBRIJA (levodopa inhalation powder)

Snippet

SUPPL AP for INBRIJA (LEVODOPA)